Literature DB >> 11432963

Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.

L W Ho1, R Brown, M Maxwell, A Wyttenbach, D C Rubinsztein.   

Abstract

OBJECTIVES: Recent data suggest that wild type huntingtin can protect against apoptosis in the testis of mice expressing full length huntingtin transgenes with expanded CAG repeats. It is not clear if this protective effect was confined to particular cell types, or if wild type huntingtin exerted its protective effect in this model by simply reducing the formation of toxic proteolytic fragments from mutant huntingtin.
METHODS: We cotransfected neuronal (SK-N-SH, human neuroblastoma) and non-neuronal (COS-7, monkey kidney) cell lines with HD exon 1 (containing either 21 or 72 CAG repeats) construct DNA and either full length wild type huntingtin or pFLAG (control vector).
RESULTS: Full length wild type huntingtin significantly reduced cell death resulting from the mutant HD exon 1 fragments containing 72 CAG repeats in both cell lines. Wild type huntingtin did not significantly modulate cell death caused by transfection of HD exon 1 fragments containing 21 CAG repeats in either cell line.
CONCLUSIONS: Our results suggest that wild type huntingtin can significantly reduce the cellular toxicity of mutant HD exon 1 fragments in both neuronal and non-neuronal cell lines. This suggests that wild type huntingtin can be protective in different cell types and that it can act against the toxicity caused by a mutant huntingtin fragment as well as against a full length transgene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432963      PMCID: PMC1757193          DOI: 10.1136/jmg.38.7.450

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  25 in total

Review 1.  Oligonucleotide therapeutic approaches for Huntington disease.

Authors:  Dinah W Y Sah; Neil Aronin
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

Review 2.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

Review 3.  Recent advances in RNA interference therapeutics for CNS diseases.

Authors:  Pavitra S Ramachandran; Megan S Keiser; Beverly L Davidson
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

4.  Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.

Authors:  Leslie G Nucifora; Kathleen A Burke; Xia Feng; Nicolas Arbez; Shanshan Zhu; Jason Miller; Guocheng Yang; Tamara Ratovitski; Michael Delannoy; Paul J Muchowski; Steven Finkbeiner; Justin Legleiter; Christopher A Ross; Michelle A Poirier
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

5.  The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology.

Authors:  Joost Schulte; J Troy Littleton
Journal:  Curr Trends Neurol       Date:  2011-01-01

6.  Evidence for dynamic and multiple roles for huntingtin in Ciona intestinalis.

Authors:  Mohammed M Idris; Michael C Thorndyke; Euan R Brown
Journal:  Invert Neurosci       Date:  2013-12

Review 7.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

8.  Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity.

Authors:  Farah H Bardai; Pragya Verma; Chad Smith; Varun Rawat; Lulu Wang; Santosh R D'Mello
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

9.  Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range.

Authors:  Pritha Majumder; Swasti Raychaudhuri; Biswanath Chattopadhyay; Nitai P Bhattacharyya
Journal:  Cell Mol Neurobiol       Date:  2007-09-28       Impact factor: 5.046

10.  FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins.

Authors:  Mirolyuba Ilieva; Troels T Nielsen; Tanja Michel; Stanislava Pankratova
Journal:  J Neural Transm (Vienna)       Date:  2019-09-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.